Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,291,051 papers from all fields of science
Search
Sign In
Create Free Account
LY2584702
Known as:
p70S6K Inhibitor LY2584702
An orally available inhibitor of p70S6K signaling, with potential antineoplastic activity. p70S6K inhibitor LY2584702 inhibits ribosomal protein S6…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (1)
LY2584702 tosylate
NCIt Antineoplastic Agent Terminology
Broader (2)
Pyrazoles
Pyrimidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
Yan Wang
,
Juncha Gao
,
Di Zhang
,
Jian Zhang
,
Jun-ji Ma
,
Hui-qing Jiang
Journal of Hepatology
2010
Corpus ID: 21745176
Highly Cited
2009
Highly Cited
2009
Silibinin inhibits hypoxia-inducible factor-1α and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy
P. García-Maceira
,
J. Mateo
Oncogene
2009
Corpus ID: 11906125
The hypoxia-inducible factor 1 (HIF-1) plays a critical role for tumour adaptation to microenvironmental hypoxia, and represents…
Expand
Highly Cited
2008
Highly Cited
2008
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.
W. Gotlieb
,
J. Saumet
,
+4 authors
I. Bruchim
Gynecologic Oncology
2008
Corpus ID: 34651367
Highly Cited
2007
Highly Cited
2007
RAD001 Inhibits Human Ovarian Cancer Cell Proliferation, Enhances Cisplatin-Induced Apoptosis, and Prolongs Survival in an Ovarian Cancer Model
S. Mabuchi
,
D. Altomare
,
+6 authors
J. Testa
Clinical Cancer Research
2007
Corpus ID: 8864446
Purpose: mTOR (mammalian target of rapamycin) plays a central role in regulating cell growth and cell cycle progression and is…
Expand
Highly Cited
2006
Highly Cited
2006
Early signaling responses to divergent exercise stimuli in skeletal muscle from well‐trained humans
Vernon G. Coffey
,
Z. Zhong
,
+4 authors
J. Hawley
The FASEB Journal
2006
Corpus ID: 34787637
Skeletal muscle from strength‐ and endurance‐trained individuals represents diverse adaptive states. In this regard, AMPK‐PGC‐1…
Expand
Highly Cited
2006
Highly Cited
2006
Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer
J. Castellví
,
Eliana García
,
+4 authors
S. Ramón y. Cajal
Cancer
2006
Corpus ID: 24686967
Growth factor receptors and cell signaling factors play a crucial role in human carcinomas and have been studied in ovarian…
Expand
Highly Cited
2006
Highly Cited
2006
Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma
C. Pelloski
,
E. Lin
,
+11 authors
K. Aldape
Clinical Cancer Research
2006
Corpus ID: 25318098
Purpose: Activation of mitogen-activated protein kinase (MAPK) and members of the Akt pathway have been shown to promote cell…
Expand
Highly Cited
1999
Highly Cited
1999
p70 S6 Kinase Is Regulated by Protein Kinase Cζ and Participates in a Phosphoinositide 3-Kinase-Regulated Signalling Complex
A. Romanelli
,
K. Martin
,
A. Toker
,
J. Blenis
Molecular and Cellular Biology
1999
Corpus ID: 26759632
ABSTRACT p70 S6 kinase (p70S6K) is an important regulator of cell proliferation. Its activation by growth factor requires…
Expand
Highly Cited
1996
Highly Cited
1996
Rapamycin resistance tied to defective regulation of p27Kip1
Yan Luo
,
S. Marx
,
H. Kiyokawa
,
A. Koff
,
J. Massagué
,
Andandrew R. Marks
Molecular and Cellular Biology
1996
Corpus ID: 22601117
The potent antiproliferative activity of the macrolide antibiotic rapamycin is known to involve binding of the drug to its…
Expand
Highly Cited
1994
Highly Cited
1994
Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression
R. P. Groot
,
L. Ballou
,
P. Sassone-Corsi
Cell
1994
Corpus ID: 33911017
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE